N/A
N=23
Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P)
Health Behavior, Risky · Health Knowledge, Attitudes, Practice · Health-Related Behavior
Bottom Line
View on ClinicalTrials.gov: NCT06307028 ↗Enrolled (actual)
23
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: Feasibility of the Intervention Scale — 4.78 units on a scale — p=.001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- SISTA-P Intervention (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Rutgers, The State University of New Jersey
- Primary completion
- Nov 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of the Intervention Scale |
4.78 | .001 sig |
| PRIMARY Acceptability of the Intervention Scale |
4.72 | .001 sig |
| PRIMARY Appropriateness of the Intervention Scale |
4.83 | .001 sig |
| PRIMARY Behavioral Intentions (Post-test) |
3.85 | < .05 sig |
| SECONDARY Number of Participants Enrolled Out of All Eligible Participants |
23 | — |
| SECONDARY Number of Participants Enrolled That Are Potentially PrEP Eligible Black Women |
23 | — |
| SECONDARY Acceptability of the Intervention Delivery (Acceptability) |
9.90 | — |
| SECONDARY Participant Retention |
20 | — |
| SECONDARY Visual Confirmation of Self-reported PrEP Uptake |
3 | — |
| SECONDARY Number of Participants Who Completed Post-intervention Surveys |
20 | — |
Summary
In this project, the investigators will provide a new HIV prevention training and empowerment sessions to Black women in Washington D.C., Atlanta and New Orleans, who are at high risk for getting HIV. This training is tailored to the experience of Black women and seeks to reduce the high HIV transmission rates in the Black community.
Eligibility Criteria
Inclusion Criteria
- Black women are eligible if you:
- Have sex with men
- Are age 18+
- Live in Washington D.C., Atlanta, GA, or New Orleans, LA
- Are not HIV+
Exclusion Criteria
- HIV+
Data sourced from ClinicalTrials.gov (NCT06307028). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.